Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,637-9,648 of 23,847
Drug study icon
CompletedNCT00239356

Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ottawa
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
France, Canada, United Kingdom, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00102063

Aripiprazole in Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00110461

Aripiprazole in Children and Adolescents With Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Scottsdale
BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00194038

Aripiprazole in Late Life Bipolarity

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

Remote / online
BipolarityDrugOver 50 Years
Countries
Sponsor
University Hospitals Cleveland Medical Center
Condition
Bipolarity
Drug study icon
CompletedNCT00095511

Aripiprazole in people with Acute Mania

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Tuscaloosa
BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00226317

Aripiprazole in the Treatment of Depression in bipolarity

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In Cambridge
Bipolarity, DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Cambridge Health Alliance
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.